Literature DB >> 22866215

Multivariate analysis of the prognostic significance of resection weight after transurethral resection of bladder tumor for non-muscle-invasive bladder cancer.

Dae Hyeon Kwon1, Phil Hyun Song, Hyun Tae Kim.   

Abstract

PURPOSE: Tumor size and multiplicity are known to be important prognostic factors in non-muscle-invasive bladder cancer (NMIBC). However, evaluation of accurate tumor size is subjective and difficult. Furthermore, there are limitations to the objectification of tumor volume in the case of multiple lesions. In this study, we investigated the relation between resection weight after transurethral resection of bladder tumor (TURBT) and the prognosis of NMIBC.
MATERIALS AND METHODS: This was a retrospective analysis of 406 patients diagnosed with pTa or pT1 bladder tumors after TURBT between September 1999 and May 2010. The patient's age, sex, underlying diseases, cancer stage, grade, multiplicity, tumor size, lymphovascular invasion, and resection weight were analyzed in relation to cancer progression and recurrence. The resection weight was weighted after formaldehyde fixation.
RESULTS: The mean follow-up time was 76.9 months (range, 12 to 167 months) in 406 patients diagnosed as having NMIBC. Mean resection weight was 4.5 g (range, 0.1 to 35.0 g). The cancer recurred in 99 patients (24.4%), and disease progression was noted in 30 patients (7.4%). Resection weight was categorized as greater than or less than 2 g by use of receiver operator characteristic curves. Cancer grade (p=0.022) and multiplicity (p=0.043) were significantly related to cancer recurrence in the analysis with Cox's multivariate proportional hazard model. Cancer grade (p=0.001) and resection weight (p=0.018) were related to disease progression.
CONCLUSIONS: Resection weight after TURBT was significantly related to progression of NMIBC. Resection weight was an independent factor of progression. Further management should be considered if the resection weight exceeds 2 g.

Entities:  

Keywords:  Prognosis; Tumor burden; Urinary bladder neoplasms

Year:  2012        PMID: 22866215      PMCID: PMC3406190          DOI: 10.4111/kju.2012.53.7.457

Source DB:  PubMed          Journal:  Korean J Urol        ISSN: 2005-6737


  14 in total

Review 1.  Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update.

Authors:  M Craig Hall; Sam S Chang; Guido Dalbagni; Raj Som Pruthi; John Derek Seigne; Eila Curlee Skinner; J Stuart Wolf; Paul F Schellhammer
Journal:  J Urol       Date:  2007-12       Impact factor: 7.450

2.  Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.

Authors:  Lakshmi P Kunju; Li You; Yingxi Zhang; Stephanie Daignault; James E Montie; Cheryl T Lee
Journal:  J Urol       Date:  2008-09-17       Impact factor: 7.450

Review 3.  Urinary bladder masses: techniques, imaging spectrum, and staging.

Authors:  Manjiri K Dighe; Puneet Bhargava; Jonathan Wright
Journal:  J Comput Assist Tomogr       Date:  2011 Jul-Aug       Impact factor: 1.826

4.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

5.  Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

Authors:  Richard J Sylvester; Adrian P M van der Meijden; Willem Oosterlinck; J Alfred Witjes; Christian Bouffioux; Louis Denis; Donald W W Newling; Karlheinz Kurth
Journal:  Eur Urol       Date:  2006-01-17       Impact factor: 20.096

6.  Prevalence and spectrum of microsatellite alterations in nonmuscle invasive bladder cancers.

Authors:  Guillaume Legrand; Hany Soliman; Francis Dubosq; Jérôme Vérine; François Desgrandchamps; Hugues de Thé; Pierre Mongiat-Artus; Guillaume Ploussard
Journal:  Am J Cancer Res       Date:  2011-04-05       Impact factor: 6.166

7.  The application of a prognostic factor analysis for Ta.T1 bladder cancer in routine urological practice.

Authors:  J Reading; R R Hall; M K Parmar
Journal:  Br J Urol       Date:  1995-05

8.  Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.

Authors:  Kang Su Cho; Ho Kyung Seo; Jae Young Joung; Weon Seo Park; Jae Y Ro; Kyung Seok Han; Jinsoo Chung; Kang Hyun Lee
Journal:  J Urol       Date:  2009-10-17       Impact factor: 7.450

Review 9.  Bladder cancer.

Authors:  Daniel A Barocas; Peter E Clark
Journal:  Curr Opin Oncol       Date:  2008-05       Impact factor: 3.645

Review 10.  Environmental factors promoting bladder cancer.

Authors:  Yoshihiko Hirao; Wun-Jae Kim; Kiyohide Fujimoto
Journal:  Curr Opin Urol       Date:  2009-09       Impact factor: 2.309

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.